BGL Announces the Recapitalization of Athenix Body Sculpting Institute

Brown Gibbons Lang & Company (BGL), a leading healthcare investment banking and financial advisory firm, is pleased to announce the recapitalization of Athenix Body Sculpting Institute (Athenix), a premier provider of body sculpting and contouring services, by Latticework Capital management (LCM). BGL’s Healthcare & Life Sciences investment banking team initiated the plastic surgery industry transaction and acted as the exclusive financial advisor to Athenix. The specific terms of the transaction were not disclosed.

Athenix offers a comprehensive suite of surgical and minimally invasive services for the body, face, and breasts in safe, convenient, and upscale settings through its five plastic surgery centers along the West Coast. The company offers a range of treatments, from a single procedure to a complete transformation, and its ability to tailor patient solutions is unmatched by competitors. Spurred by fanatic patient results and a growing demand for aesthetic procedures, Athenix has grown into an industry leader on the West Coast with plans for national expansion.

Headquartered in Dallas, Latticework is a growth oriented private equity firm focused exclusively on the healthcare industry. Latticework leverages its over 70 combined years of healthcare experience, as well as its network of industry executives, to help companies grow and realize their full long-term value.

BGL’s Healthcare Provider Services Group is one of the most experienced and respected financial advisory teams in the U.S. for physician practice M&A, plastic surgery M&A and related technical services, with a long track record of expertise in physician practice valuation and in successfully advising physicians and alternate site providers through strategic transactions like selling a physician practice. With healthcare investment banking industry expertise, tenacious processing, and creative deal structuring, coupled with global access to the most active healthcare and life sciences investors, BGL’s advisors execute transactions effectively and efficiently, and consistently exceed our clients’ expectations.